✦ LIBER ✦

Sa2032 Infliximab for Moderate to Severe Ulcerative Colitis: Short and Long-Term Effects and Predictors of Response

✍ Scribed by Ron, Yulia; Yanai, Henit; Yehoyada, Merav Ben; Meirovithz, Elhanan; Yahav, Lior; Yeshurun, Dror; Santo, Erwin; Dotan, Iris

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P272 Infliximab for moderate to severe u

✍ Y. Ron; H. Yanai; M. Ben Yehoyada; E. Meirovithz; L. Yahav; D. Yeshurun; E. Sant 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 65 KB

409 Adalimumab for Ulcerative Colitis Pa

✍ Carlos Taxonera; Jesús Estellés; Ignacio Blanco; Olga Merino; Ignacio Marin-Jime 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Sa1108 Cost-Effectiveness of Golimumab V

✍ Thorlund, Kristian; Druyts, Eric; Kanters, Steve; Eapen, Shawn; Mills, Edward 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Sa1902 Short- and Long-Term Outcomes of

✍ Taxonera, Carlos; Acosta, Manuel Barreiro-de; Calvo, Marta; Saro, Cristina; Bast 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Infliximab in severe ulcerative colitis:

✍ A. KOHN; M. DAPERNO; A. ARMUZZI; M. CAPPELLO; L. BIANCONE; A. ORLANDO; A. VISCID 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

A model of the long-term cost effectiven

✍ H. H. TSAI; Y. S. PUNEKAR; J. MORRIS; P. FORTUN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB